Yuyu Pharma, Inc. (000227.KS)
KRW 9750.0
(-0.41%)
KRW 9750.0
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 137.2 Billion | 138.88 Billion | 115.65 Billion | 98.11 Billion | 90.87 Billion | 83.09 Billion |
| Cost of Revenue | 90.7 Billion | 85.56 Billion | 70.32 Billion | 52.85 Billion | 44.26 Billion | 42.45 Billion |
| Gross Profit | 46.5 Billion | 53.31 Billion | 45.33 Billion | 45.26 Billion | 46.61 Billion | 40.63 Billion |
| Operating Expenses | 47.25 Billion | 53.9 Billion | 44.13 Billion | 38.99 Billion | 38.53 Billion | 35.3 Billion |
| Selling, General and Administrative Expenses | 15.89 Billion | 19.99 Billion | 16.37 Billion | 14.13 Billion | 16.05 Billion | 15.08 Billion |
| Research and Development Expenses | 7.18 Billion | 8.62 Billion | 4 Billion | 4.12 Billion | 876.67 Million | 1.42 Billion |
| Other Expenses | 25.44 Billion | 25.29 Billion | 23.75 Billion | 20.74 Billion | 21.6 Billion | 322.19 Million |
| Cost and Expenses | 137.95 Billion | 139.47 Billion | 114.45 Billion | 91.84 Billion | 82.8 Billion | 77.76 Billion |
| Operating Income | 364.53 Million | 691.74 Million | 2.65 Billion | 6.27 Billion | 8.07 Billion | 5.32 Billion |
| Interest Expense | 2.55 Billion | 2.58 Billion | 2.17 Billion | 1.75 Billion | 1.78 Billion | 1.12 Billion |
| Income Tax Expense | 98.43 Million | 615.01 Million | 537.13 Million | 1.29 Billion | 1.03 Billion | 336.12 Million |
| Earnings before Tax | -5.44 Billion | -3.81 Billion | -383.15 Million | 3.71 Billion | 6.6 Billion | 4.64 Billion |
| Net Income | -7.18 Billion | -4.42 Billion | -920.28 Million | 2.41 Billion | 4.72 Billion | 4.02 Billion |
| Earnings Per Share Basic | -441.41 | -266.90 | -57.67 | 194.34 | 377.83 | 281.50 |
| Earnings Per Share Diluted | -441.41 | -266.90 | -57.67 | 194.34 | 376.31 | 281.50 |
| Weighted Average Shares Outstanding | 16.26 Million | 16.58 Million | 15.95 Million | 12.41 Million | 11.74 Million | 14.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.26 Million | 16.58 Million | 15.95 Million | 12.41 Million | 14.99 Million | 14.28 Million |
| Gross Margin | 0.34 | 0.38 | 0.39 | 0.46 | 0.51 | 0.49 |
| EBIT Margin | 0.04 | 0.04 | 0.06 | 0.09 | 0.12 | 0.10 |
| Profit Margin | -0.05 | -0.03 | -0.01 | 0.02 | 0.05 | 0.05 |
| EBITDA | 4.85 Billion | 3.4 Billion | 5.7 Billion | 10.17 Billion | 11.18 Billion | 7.45 Billion |
| Earnings Before Tax Margin | 0.00 | 0.00 | 0.02 | 0.06 | 0.09 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 33.17 Billion | 33.4 Billion | 34.6 Billion | 137.2 Billion | 34.09 Billion | 34.21 Billion |
| Cost of Revenue | 20.76 Billion | 19.86 Billion | 23.94 Billion | 90.7 Billion | 22.88 Billion | 21.67 Billion |
| Gross Profit | 12.4 Billion | 13.53 Billion | 10.66 Billion | 46.5 Billion | 11.2 Billion | 12.54 Billion |
| Operating Expenses | 8.34 Billion | 8.87 Billion | 10.91 Billion | 47.25 Billion | -12.71 Billion | 12.92 Billion |
| Selling, General and Administrative Expenses | 8.07 Billion | 8.05 Billion | 10.09 Billion | - | 12.71 Billion | 3.78 Billion |
| Research and Development Expenses | 498.77 Million | 519.72 Million | 766.41 Million | - | 1.2 Billion | 2.6 Billion |
| Other Expenses | 234.19 Million | -303.53 Million | -57.36 Million | -219.22 Million | -25.42 Billion | -198.58 Million |
| Cost and Expenses | 29.11 Billion | 28.73 Billion | 34.85 Billion | 137.95 Billion | 22.88 Billion | 34.59 Billion |
| Operating Income | 4.06 Billion | 4.66 Billion | -251.3 Million | -748.94 Million | -1.51 Billion | -380.17 Million |
| Interest Expense | 805.59 Million | 920.2 Million | 165.55 Million | 2.55 Billion | 797.79 Million | 895.61 Million |
| Income Tax Expense | 620.82 Million | 54.79 Million | -474.83 Million | 98.43 Million | -84.37 Million | 599.05 Million |
| Earnings before Tax | 2.58 Billion | 5.64 Billion | -1.13 Billion | -4.94 Billion | -2.36 Billion | -2.57 Billion |
| Net Income | 1.24 Billion | 5.17 Billion | -1.08 Billion | -7.18 Billion | -2.73 Billion | -3.45 Billion |
| Earnings Per Share Basic | 66.58 | 319.88 | -67.14 | - | -167.60 | -213.76 |
| Earnings Per Share Diluted | 66.58 | 319.88 | -67.14 | - | -167.60 | -213.76 |
| Weighted Average Shares Outstanding | 16.18 Million | 16.18 Million | 16.18 Million | 16.26 Million | 16.29 Million | 16.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.18 Million | 16.18 Million | 16.18 Million | 16.26 Million | 16.29 Million | 16.18 Million |
| Gross Margin | 0.37 | 0.41 | 0.31 | 0.34 | 0.33 | 0.37 |
| EBIT Margin | 0.17 | 0.18 | 0.03 | - | 0.33 | 0.02 |
| Profit Margin | 0.04 | 0.15 | -0.03 | -0.05 | -0.08 | -0.10 |
| EBITDA | 5.5 Billion | 6.06 Billion | 1.2 Billion | - | 11.2 Billion | 660.69 Million |
| Earnings Before Tax Margin | 0.12 | 0.14 | -0.01 | -0.01 | -0.04 | -0.01 |
ASGR
JAIPURKURT
002498
DUVNF
ASYL
SLRN